Pharmacogenetics and other reasons why drugs can fail in pregnancy: Higher dose or different drug?

David M. Haas, Mary D'Alton

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Changes in maternal physiology during pregnancy can alter the absorption, distribution, and clearance of many drugs. When presented with a clinical situation in which it does not appear that a prescribed drug is working, clinicians must either change drugs or increase the dose of the current drug to achieve the desired clinical effect. A case highlighting antihypertensive medication in pregnancy and the effect of changed drug-metabolizing enzymes is presented. Understanding pregnancy's effect on drug-metabolizing enzymes, transporters, and receptors can help clinicians make individualized pharmacotherapeutic decisions for patients. Pharmacogenetics potentially can aid clinicians in treating pregnant women in the future as more data are generated and individualized therapeutic models are constructed.

Original languageEnglish (US)
Pages (from-to)1176-1179
Number of pages4
JournalObstetrics and gynecology
Volume120
Issue number5
DOIs
StatePublished - Nov 2012

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Pharmacogenetics and other reasons why drugs can fail in pregnancy: Higher dose or different drug?'. Together they form a unique fingerprint.

  • Cite this